Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Return on Invested Capital (2022 - 2025)

Sutro Biopharma (STRO) has disclosed Return on Invested Capital for 4 consecutive years, with 0.29% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital changed N/A to 0.29% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.29% through Dec 2025, changed N/A year-over-year, with the annual reading at 0.56% for FY2023, 3.0% down from the prior year.
  • Return on Invested Capital hit 0.29% in Q4 2025 for Sutro Biopharma, down from 2.77% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 6.51% in Q2 2025 to a low of 1.29% in Q3 2023.
  • Historically, Return on Invested Capital has averaged 0.33% across 4 years, with a median of 0.71% in 2023.
  • Biggest five-year swings in Return on Invested Capital: fell -23bps in 2023 and later skyrocketed 750bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.56% in 2022, then tumbled by -41bps to 0.79% in 2023, then crashed by -46bps to 1.15% in 2024, then surged by 125bps to 0.29% in 2025.
  • Business Quant data shows Return on Invested Capital for STRO at 0.29% in Q4 2025, 2.77% in Q3 2025, and 6.51% in Q2 2025.